RNS Number : 9201T
Park Group PLC
06 July 2018
Park Group plc
("Park" the "Company" or the "Group")
Director Share Dealing
The Company has been informed that on 6 July 2018 Michael de Kare-Silver, Non-Executive Director of Park, acquired 10,000 ordinary shares of 2 pence each in the Company ("Ordinary Shares") at a price of 73.5 pence per Ordinary Share.
For further information please contact:
|
Park Group plc
|
Arden Partners plc
|
Tavistock
|
|
Ian O'Doherty
|
Steve Douglas
Benjamin Cryer
|
Jeremy Carey
Sophie Praill
|
|
Tel: 0151 653 1700
|
Tel: 020 7614 5920
|
Tel: 020 7920 3150
|
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a)
|
Name
|
Michael de Kare-Silver
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Director
|
|
b)
|
Initial notification /Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Park Group plc
|
|
b)
|
LEI
|
213800MQ5U1F8SPHK638
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 2p each
ISIN : GB0006710643
|
|
b)
|
Nature of the transaction
|
Purchase of ordinary shares
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
£0.735
|
10,000
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A (Single transaction)
|
|
e)
|
Date of the transaction
|
6 July 2018
|
|
f)
|
Place of the transaction
|
XLON
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
DSHRFMATMBBMBAP